# Ajax Health

> Ajax Health is a healthcare investment and operating firm that builds and scales medical technology businesses. It combines capital, executive support, clinical expertise, and partnerships with established companies to develop product portfolios with a route to commercialization.

- **Founded:** 2017
- **Headquarters:** Menlo Park, United States
- **Founders:** Duke Rohlen (Founder, CEO & Managing Partner)
- **Products:** Medtech investment and operating support, Cordis-X, Maverix Medical, Cortex, FlowMod
- **Notable:** Established Cordis-X as an independent innovation accelerator in 2021., Launched Maverix Medical with KKR and Hologic in November 2023., Cortex acquisition closed January 24, 2025, with $248 million paid upfront net of cash acquired and up to approximately $50 million in regulatory milestones.

## Products & services

- **Medtech investment and operating support** — Capital and hands-on leadership for healthcare businesses, including finance, clinical, engineering, and commercialization capabilities.
- **Cordis-X** — Independent accelerator developing and investing in technologies for the Cordis vascular device portfolio.
- **Maverix Medical** — Lung cancer platform established with KKR and Hologic; includes diagnostics development and medical devices.
- **Cortex** — Former Ajax company developing AFib mapping and ablation technologies; acquired by Boston Scientific in January 2025.
- **FlowMod** — Platform formed with KKR and Boston Scientific to develop a heart failure system using Boston Scientific intellectual property.
- **Narwhal Cryo System (Maverix portfolio)** — Single-use, console-free cryoprobe manufactured by Serpex Medical and distributed through Maverix; FDA clearance announced in August 2026.

## Achievements

- Established Cordis-X as an independent innovation accelerator in 2021.
- Launched Maverix Medical with KKR and Hologic in November 2023.
- Cortex acquisition closed January 24, 2025, with $248 million paid upfront net of cash acquired and up to approximately $50 million in regulatory milestones.
- Maverix announced Narwhal Cryo System 510(k) clearance in August 2026; clearance was granted June 30.

## Latest updates

- **2026-08** — Maverix announced FDA 510(k) clearance for its Narwhal Cryo System on August 20, following clearance on June 30.
- **2026-07** — Maverix appointed Carla Jung CEO on July 23.
- **2025-03** — Ajax and KKR announced FlowMod in collaboration with Boston Scientific.
- **2025-01** — Boston Scientific completed its acquisition of Cortex on January 24.

## Links

- Website: https://ajaxhealth.com/
- LinkedIn: https://www.linkedin.com/company/ajaxhealth/
- Twitter/X: https://x.com/ajax_health

---

Profile page: https://yespress.io/ajax-health
Published by YesPress — https://yespress.io
Last updated: 2026-10-03